kane biotech inc (KNE:Venture)
Executive Profile*
Gord FroehlichChief Executive Officer, President, Director and Member of Audit Committee, Kane Biotech Inc. |
| Age | Total Calculated Compensation | This person is connected to 8 board members in 1 different organizations across 2 different industries. See Board Relationships |
| -- | C$250,338 As of Fiscal Year 2011 |
Background*
Mr. Gord Froehlich has been Chief Executive Officer of Kane Biotech Inc. since May 23, 2007 and also has been its President since March 21, 2006. Mr. Froehlich served as Vice President of Business Development at Genesys Venture Inc. He brings broad experience in leadership and business development to the Genesys Venture Inc. team. Previously Mr. Froehlich was the Director for Biotechnology and Seed and a Vice President with Monsanto Canada. He has a firm understanding ...
Corporate Headquarters*162-196 Innovation DriveWinnipeg, Manitoba R3T 2N2 Canada Phone: 204-453-1301 Fax: 204-474-7552 Board Members Memberships*2006-2007 Former Director and Member of Audit Committee 2012-Present Chief Executive Officer, President, Director and Member of Audit Committee
Education*There is no Education data available.Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| KNE:CN | C$0.09 CAD | -0.005 |  |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact KANE BIOTECH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
